Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$10.4M Sell
58,709
-593
-1% -$98.5K 1.63% 14
2016
Q4
$8.67M Sell
59,302
-10,701
-15% -$1.61M 1.43% 18
2016
Q3
$11.7M Buy
70,003
+83
+0.1% +$14K 1.96% 7
2016
Q2
$10.6M Sell
69,920
-822
-1% -$128K 1.81% 8
2016
Q1
$10.6M Buy
70,742
+537
+0.8% +$79.8K 1.84% 10
2015
Q4
$11.4M Buy
70,205
+2,037
+3% +$320K 1.98% 9
2015
Q3
$9.43M Sell
68,168
-558
-0.8% -$88K 1.66% 10
2015
Q2
$10.6M Buy
68,726
+303
+0.4% +$48.5K 1.7% 9
2015
Q1
$10.9M Buy
68,423
+810
+1% +$128K 1.66% 12
2014
Q4
$10.8M Buy
67,613
+1,612
+2% +$251K 1.66% 10
2014
Q3
$9.27M Buy
66,001
+3,232
+5% +$422K 1.53% 13
2014
Q2
$7.43M Sell
62,769
-4,681
-7% -$542K 1.22% 24
2014
Q1
$8.32M Buy
67,450
+20,840
+45% +$2.53M 1.42% 16
2013
Q4
$5.32M Buy
46,610
+17,700
+61% +$2.01M 0.91% 43
2013
Q3
$3.24M Buy
28,910
+22,746
+369% +$2.47M 0.6% 64
2013
Q2
$608K Buy
+6,164
New +$640K 0.12% 114

Other funds holding AMGN

Beacon Trust's AMGN Position: Q1 2017 in Review

Beacon Trust reduced its Amgen (AMGN) stake by 1% in Q1 2017, selling an estimated $98.5K and leaving 58,709 shares worth $10.4M. The position accounts for 1.63% of the portfolio, ranked #14.

Beacon Trust first reported a position in AMGN in Q2 2013 and has held it in 16 quarters since. The position peaked at $11.7M in Q3 2016. 1,600 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.

  • Beacon Trust held 58,709 shares of Amgen worth $10.4M as of Q1 2017.
  • Beacon Trust sold 593 Amgen shares in Q1 2017, an estimated $98.5K.
  • Amgen made up 1.63% of Beacon Trust's portfolio in Q1 2017, its #14 holding.
  • Beacon Trust first reported a position in Amgen in Q2 2013 and has held it in 16 quarters since.
  • Beacon Trust's Amgen position peaked at $11.7M in Q3 2016.
  • 1,600 funds tracked by Wall St. Rank held Amgen as of Q1 2017.

Based on Beacon Trust's 13F filing for Q1 2017, filed 9 May 2017.